Regulatory Framework of Clinical Trials in BRIC Nations

Aug 4, 2014

Long heralded by global sponsors as cost-effective alternatives to western markets, the BRIC nations – Brazil, Russia, India, and China – are experiencing declines in the number of clinical drug trials initiated. But the benefits of conducting clinical research in these countries remain ...

Read More